BioVersys

BioVersys

Switzerland - Basel
Biotechnology
WebsiteLinkedInCareers Page

Focus: Drug Discovery

BioVersys is a life sciences company focused on Drug Discovery.

Infectious DiseasesNephrology
Funding Stage
PUBLIC
Open Jobs
1

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT05258877Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis.
N/A
Phase 1
Clinical Trials (1)
NCT05087069Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male Subjects
Phase 1
Phase 1
Clinical Trials (1)
NCT05684718To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100
Phase 1
Phase 1
Clinical Trials (1)
NCT05086107Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment
Phase 1
BVL-GSK098 capsule, placebo
Healthy Volunteers
Phase 1
Clinical Trials (1)
NCT04654143Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BVL-GSK098 in Healthy Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT05537142A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment
Phase 1
Phase 1
Clinical Trials (1)
NCT05684705Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100
Phase 1
Phase 1
Clinical Trials (1)
NCT04636983Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects
Phase 1
Phase 1
Clinical Trials (1)
NCT05537090A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants
Phase 1
BV100 plus Polymyxin B
Ventilator Associated Pneumonia
Phase 2
Clinical Trials (1)
NCT05685615PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
Phase 2
BV100 with 50 mg polymyxin B plus ceftazidime/avibactam
Ventilator Associated Bacterial Pneumonia (VABP)
Phase 2
Clinical Trials (1)
NCT07431307Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
Phase 2
Phase 2
Clinical Trials (1)
NCT07350174Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis
Phase 2
Phase 3
Clinical Trials (1)
NCT07326540Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
Phase 3

Open Jobs (1)

Medical Monitor (Clinical Development – Infectious Diseases)

Unknown
Unknown
2w ago
Interview Prep Quick Facts
Portfolio: 13 clinical trials
Open Roles: 1 active job